Roche

RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

www.roche.com.

Roche RSS Channel

Display # 
Title Published Date
Roche reports solid sales growth in the first quarter of 2016 19 April 2016
FDA grants priority review for Roche's cancer immunotherapy atezolizumab in specific type of lung cancer 15 April 2016
FDA grants Roche's Cancer Immunotherapy Atezolizumab priority review for advanced bladder cancer 15 March 2016
U.S. FDA grants Breakthrough Therapy Designation for Roche's investigational medicine ocrelizumab in primary progressive multiple sclerosis 17 February 2016
Roche and Upsher-Smith announce license agreement to develop novel VAP-1 inhibitor 02 December 2015
Roche receives EU approval of Cotellic for use in combination with Zelboraf in advanced melanoma 25 November 2015
Roche to restructure its manufacturing network for small molecules 18 November 2015
Roche delivers strong sales growth in the first nine months of 2015 26 October 2015
Roche's ocrelizumab first investigational medicine to show positive pivotal study results in both relapsing and primary progressive forms of multiple sclerosis 09 October 2015
New Roche Esbriet data show clinical benefits of continued and long-term treatment in patients with idiopathic pulmonary fibrosis (IPF) 01 October 2015
For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 14 September 2015
"Roche Continents" fosters innovation in science and art 11 August 2015
Roche employees unite to raise funds for children in need 16 June 2015
Roche reports strong sales growth in the first quarter of 2015 23 April 2015
Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics 11 February 2015
Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need 20 January 2015
Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology 12 January 2015
Roche to invest 450 million Swiss Francs in new diagnostic manufacturing facility in China 05 November 2014
Roche delivers solid sales growth for the first nine months of 2014 19 October 2014
Roche again ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 14 September 2014

Most Popular Now

AstraZeneca and Eli Lilly and Compa…

AstraZeneca and Eli Lilly and Company today announced that AMARANTH, a Phase II/III study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in...

Read more

NIH launches large clinical trials …

Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection. Known as the A...

Read more

Pfizer announces termination of pro…

Pfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The deci...

Read more

New analysis shows only minority of…

Boehringer Ingelheim has announced a new publication showing that levels of white blood cells called eosinophils can help identify patients with COPD who may and may not ...

Read more

Researchers open the way to new tre…

In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length struc...

Read more

Implantable device targets pancreat…

Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, whi...

Read more

Physicians' knowledge about FDA app…

Since 2012, the FDA can designate a drug as a "breakthrough therapy" if preliminary clinical evidence - such as an improvement in a pharmacodynamic biomarker - suggests a...

Read more

FDA grants priority review for Roch…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) and granted P...

Read more

Global spending on health is expect…

Global inequities in health spending are expected to persist and intensify over the next 25 years, according to a new study that estimates total health financing in count...

Read more

Americans live longer but with disa…

Americans are living longer but in poorer health, according to a new study. The USC-led study examined life expectancy trends and disability rates in a 40-year period, fr...

Read more

Nanoparticles show promise for trea…

Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease (IBD), according to...

Read more

Johnson & Johnson announces lau…

Johnson & Johnson today announced the official launch of its global public health strategy at the opening of its companies' on-the-ground global public health operations ...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]